111, Inc. (NASDAQ:YI) Short Interest Update

111, Inc. (NASDAQ:YIGet Free Report) was the target of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 15,200 shares, a decline of 49.0% from the March 31st total of 29,800 shares. Based on an average daily volume of 65,600 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Trading of 111

An institutional investor recently bought a new position in 111 stock. Tower Research Capital LLC TRC purchased a new stake in 111, Inc. (NASDAQ:YIFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 18,558 shares of the company’s stock, valued at approximately $29,000. Institutional investors own 21.32% of the company’s stock.

111 Stock Down 3.8 %

NASDAQ YI opened at $1.01 on Friday. The stock’s 50-day moving average price is $1.25 and its 200-day moving average price is $1.64. The company has a market capitalization of $84.35 million, a P/E ratio of -1.55 and a beta of 0.38. 111 has a 52 week low of $0.97 and a 52 week high of $3.36.

111 (NASDAQ:YIGet Free Report) last issued its quarterly earnings data on Thursday, March 21st. The company reported ($0.34) earnings per share for the quarter. The firm had revenue of $578.69 million during the quarter.

111 Company Profile

(Get Free Report)

111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.

Further Reading

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.